Fewer species and high numbers of particular bacteria linked to heightened risk ... Dec 15
The data will be further analyzed to determine any potential impact on other studies of ruxolitinib in patients with COVID-19, and will be submitted ... Dec 15
The acquisition will establish a new modality for drug discovery and development at Lilly ... Dec 15
-Advertisements-